Meconium inhibits the contraction of umbilical vessels induced by the thromboxane A2 analog U46619

Lynn D. Montgomery, Michael A. Belfort, George Saade, Kenneth J. Moise, Yuri P. Vedernikov

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

OBJECTIVE: Our objective was to study the direct effects of meconium on isolated umbilical artery and vein in vitro. STUDY DESIGN: Intact umbilical artery and vein rings were suspended in 5 ml organ baths containing Kreb's solution (pH 7.2, 37° C; bubbled with 2.5% oxygen and 8.07% carbon dioxide, balance nitrogen) for isometric tension recording. Meconium alone (final bath concentration 1%), centrifuged and filtered meconium, and meconium with the lipid fraction removed (separated into < 30,000 kd and >30,000 kd) were added to the baths. Some vessels were also incubated in 1% meconium for 30 minutes, after which the meconium was washed out. Concentration-response curves to U46619 were obtained. The negative log of the concentration that evokes 50% of the maximal contraction was determined. RESULTS: Umbilical artery and vein had no sustained response to meconium. Tension that developed by rings exposed to meconium was significantly less than control at all concentrations of U46619. There was some loss of the efficacy of meconium after centrifugation-filtration and washing out. Meconium without the lipid fraction had less inhibitory effect than did native meconium. CONCLUSION: Meconium does not cause sustained contraction of umbilical artery and vein in vitro. It does, however, inhibit the contractile effect of U46619 in both umbilical artery and vein smooth muscle. The inhibitory activity of meconium appears to be concentrated in the lipid fraction.

Original languageEnglish (US)
Pages (from-to)1075-1078
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Volume173
Issue number4
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Umbilicus
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Meconium
Thromboxane A2
Umbilical Veins
Umbilical Arteries
Baths
Lipids
Centrifugation
Carbon Dioxide
Smooth Muscle

Keywords

  • Meconium
  • thromboxane A
  • U46619
  • umbilical vessel

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Meconium inhibits the contraction of umbilical vessels induced by the thromboxane A2 analog U46619. / Montgomery, Lynn D.; Belfort, Michael A.; Saade, George; Moise, Kenneth J.; Vedernikov, Yuri P.

In: American Journal of Obstetrics and Gynecology, Vol. 173, No. 4, 1995, p. 1075-1078.

Research output: Contribution to journalArticle

Montgomery, Lynn D. ; Belfort, Michael A. ; Saade, George ; Moise, Kenneth J. ; Vedernikov, Yuri P. / Meconium inhibits the contraction of umbilical vessels induced by the thromboxane A2 analog U46619. In: American Journal of Obstetrics and Gynecology. 1995 ; Vol. 173, No. 4. pp. 1075-1078.
@article{7d7d543195194469bf0efbef2618e143,
title = "Meconium inhibits the contraction of umbilical vessels induced by the thromboxane A2 analog U46619",
abstract = "OBJECTIVE: Our objective was to study the direct effects of meconium on isolated umbilical artery and vein in vitro. STUDY DESIGN: Intact umbilical artery and vein rings were suspended in 5 ml organ baths containing Kreb's solution (pH 7.2, 37° C; bubbled with 2.5{\%} oxygen and 8.07{\%} carbon dioxide, balance nitrogen) for isometric tension recording. Meconium alone (final bath concentration 1{\%}), centrifuged and filtered meconium, and meconium with the lipid fraction removed (separated into < 30,000 kd and >30,000 kd) were added to the baths. Some vessels were also incubated in 1{\%} meconium for 30 minutes, after which the meconium was washed out. Concentration-response curves to U46619 were obtained. The negative log of the concentration that evokes 50{\%} of the maximal contraction was determined. RESULTS: Umbilical artery and vein had no sustained response to meconium. Tension that developed by rings exposed to meconium was significantly less than control at all concentrations of U46619. There was some loss of the efficacy of meconium after centrifugation-filtration and washing out. Meconium without the lipid fraction had less inhibitory effect than did native meconium. CONCLUSION: Meconium does not cause sustained contraction of umbilical artery and vein in vitro. It does, however, inhibit the contractile effect of U46619 in both umbilical artery and vein smooth muscle. The inhibitory activity of meconium appears to be concentrated in the lipid fraction.",
keywords = "Meconium, thromboxane A, U46619, umbilical vessel",
author = "Montgomery, {Lynn D.} and Belfort, {Michael A.} and George Saade and Moise, {Kenneth J.} and Vedernikov, {Yuri P.}",
year = "1995",
doi = "10.1016/0002-9378(95)91329-7",
language = "English (US)",
volume = "173",
pages = "1075--1078",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Meconium inhibits the contraction of umbilical vessels induced by the thromboxane A2 analog U46619

AU - Montgomery, Lynn D.

AU - Belfort, Michael A.

AU - Saade, George

AU - Moise, Kenneth J.

AU - Vedernikov, Yuri P.

PY - 1995

Y1 - 1995

N2 - OBJECTIVE: Our objective was to study the direct effects of meconium on isolated umbilical artery and vein in vitro. STUDY DESIGN: Intact umbilical artery and vein rings were suspended in 5 ml organ baths containing Kreb's solution (pH 7.2, 37° C; bubbled with 2.5% oxygen and 8.07% carbon dioxide, balance nitrogen) for isometric tension recording. Meconium alone (final bath concentration 1%), centrifuged and filtered meconium, and meconium with the lipid fraction removed (separated into < 30,000 kd and >30,000 kd) were added to the baths. Some vessels were also incubated in 1% meconium for 30 minutes, after which the meconium was washed out. Concentration-response curves to U46619 were obtained. The negative log of the concentration that evokes 50% of the maximal contraction was determined. RESULTS: Umbilical artery and vein had no sustained response to meconium. Tension that developed by rings exposed to meconium was significantly less than control at all concentrations of U46619. There was some loss of the efficacy of meconium after centrifugation-filtration and washing out. Meconium without the lipid fraction had less inhibitory effect than did native meconium. CONCLUSION: Meconium does not cause sustained contraction of umbilical artery and vein in vitro. It does, however, inhibit the contractile effect of U46619 in both umbilical artery and vein smooth muscle. The inhibitory activity of meconium appears to be concentrated in the lipid fraction.

AB - OBJECTIVE: Our objective was to study the direct effects of meconium on isolated umbilical artery and vein in vitro. STUDY DESIGN: Intact umbilical artery and vein rings were suspended in 5 ml organ baths containing Kreb's solution (pH 7.2, 37° C; bubbled with 2.5% oxygen and 8.07% carbon dioxide, balance nitrogen) for isometric tension recording. Meconium alone (final bath concentration 1%), centrifuged and filtered meconium, and meconium with the lipid fraction removed (separated into < 30,000 kd and >30,000 kd) were added to the baths. Some vessels were also incubated in 1% meconium for 30 minutes, after which the meconium was washed out. Concentration-response curves to U46619 were obtained. The negative log of the concentration that evokes 50% of the maximal contraction was determined. RESULTS: Umbilical artery and vein had no sustained response to meconium. Tension that developed by rings exposed to meconium was significantly less than control at all concentrations of U46619. There was some loss of the efficacy of meconium after centrifugation-filtration and washing out. Meconium without the lipid fraction had less inhibitory effect than did native meconium. CONCLUSION: Meconium does not cause sustained contraction of umbilical artery and vein in vitro. It does, however, inhibit the contractile effect of U46619 in both umbilical artery and vein smooth muscle. The inhibitory activity of meconium appears to be concentrated in the lipid fraction.

KW - Meconium

KW - thromboxane A

KW - U46619

KW - umbilical vessel

UR - http://www.scopus.com/inward/record.url?scp=0028863584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028863584&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(95)91329-7

DO - 10.1016/0002-9378(95)91329-7

M3 - Article

VL - 173

SP - 1075

EP - 1078

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -